Skip to main content
BioAdvance News

QR Pharma Receives US Patent 7,625,942 to Treat Down Syndrome

By February 24, 2010November 1st, 2024No Comments

QR Pharma Receives US Patent 7,625,942 to Treat Down Syndrome
Read more here